Claritev (CTEV) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
29 Apr, 2026Opening remarks and agenda
Meeting opened virtually to enable broader stockholder participation, with introductions of board members and independent auditor present.
Housekeeping details included meeting recording availability, rules, and procedures for submitting questions and voting.
Quorum confirmed, meeting officially convened, and polls for voting opened at 9:03 A.M. on April 29, 2026.
Board and executive committee updates
Four class three director nominees presented for election to serve until the 2029 annual meeting; no other nominations received.
Shareholder proposals
Four proposals presented: election of directors, ratification of PwC as auditor, advisory say-on-pay vote, and amendment to the 2020 Omnibus Incentive Plan.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Claritev
- Transformation drives growth, margin strength, and leadership in healthcare claims innovation.CTEV
Canaccord Genuity's 46th Annual Growth Conference - Q2 2026 revenue up 6.6%, guidance raised, but legal and IT risks remain.CTEV
Q2 2026 - Record bookings, tech investment, and strong client ties drive ambitious 2030 growth targets.CTEV
Bank of America Global Healthcare Conference 2026 - Q1 2026 revenue grew 5.8% to $244.7M, with margin gains but continued net losses.CTEV
Q1 2026 - 2026 guidance targets $980M–$1B revenue, 61–62% EBITDA margin, and AI-driven growth.CTEV
Investor Day 2026 - Transformation and innovation drive growth, profitability, and expanded market reach.CTEV
44th Annual J.P. Morgan Healthcare Conference - Six new market segments, tech innovation, and a $200M pipeline drive growth into 2026.CTEV
BofA Securities Leveraged Finance Conference 2025 - Q1 2025 revenue was $231.3M, net loss narrowed, and transformation advanced.CTEV
Q1 2025 - 2024 net loss surged on a $1.49B impairment as transformation and rebranding drive long-term optimism.CTEV
Q4 2024